Metabolic Syndrome Tied to Higher Risk of Endometrial Cancer

This article originally appeared here.
Share this content:
Metabolic Sx Tied to Higher Risk of Endometrial Cancer
Metabolic Sx Tied to Higher Risk of Endometrial Cancer

(HealthDay News) -- A diagnosis of metabolic syndrome is associated with higher risk of endometrial cancer, regardless of whether the patient is considered obese, according to new research published in the January issue of Cancer Epidemiology, Biomarkers & Prevention.

Britton Trabert, Ph.D., an investigator in the division of cancer epidemiology and genetics at the U.S. National Cancer Institute in Bethesda, Md., and colleagues reviewed information on 16,323 American women diagnosed with endometrial cancer between 1993 and 2007. The study authors compared those women to 100,751 women without endometrial cancer.

Overall, metabolic syndrome was associated with a 39 to 103 percent increased risk of endometrial cancer in women 65 and older. The reason for the variation in risk is that health groups have different definitions for metabolic syndrome. Being overweight is a known risk factor for endometrial cancer. But, even after the researchers accounted for excess weight, metabolic syndrome was still linked to up to a 21 percent increased risk. Each condition that contributes to metabolic syndrome was found to be independently associated with increased risk for endometrial cancer.

"Although our study was not designed to evaluate the potential impact of preventing metabolic syndrome on endometrial cancer incidence, weight loss and exercise are the most effective steps a woman can take to prevent developing metabolic syndrome," Trabert said in an American Association for Cancer Research news release.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »